use
six
monoclon
antibodi
epitop
af
glycoprotein
semliki
forest
viru
sfv
found
antigen
differ
infect
cell
viru
particl
respect
glycosyl
impair
inhibit
nmethylldeoxynojirimycin
furthermor
conclud
conform
chang
take
place
viru
bud
composit
structur
carbohydr
side
chain
attach
viral
glycoprotein
import
viru
matur
may
influenc
viru
adsorpt
penetr
transport
viral
glycoprotein
proteolyt
cleavag
precursor
protein
associ
spike
glycoprotein
antigen
semliki
forest
viru
sfv
togaviru
contain
nucleocapsid
protein
c
three
envelop
glycoprotein
el
previous
observ
viru
matur
could
inhibit
impair
glycosyl
eg
treatment
infect
cell
tunicamycin
use
polyclon
antisera
shown
addit
antigen
glycoprotein
carbohydr
side
chain
treatment
tunicamycin
truncat
chain
treatment
differ
viru
particl
use
six
monoclon
antibodi
mab
specif
six
epitop
af
virion
recent
found
chang
antigen
virion
sfv
propag
cell
presenc
nmethylldeoxynojirimycin
mdn
releas
infecti
viru
particl
contain
mannoserich
carbohydr
side
chain
composit
gi
glcnac
epitop
react
well
epitop
c
e
react
less
epitop
b
f
slightli
summari
use
six
monoclon
antibodi
epitop
af
glycoprotein
semliki
forest
viru
sfv
found
antigen
differ
infect
cell
viru
particl
respect
glycosyl
impair
inhibit
nmethylldeoxynojirimycin
furthermor
conclud
conform
chang
take
place
viru
bud
composit
structur
carbohydr
side
chain
attach
viral
glycoprotein
import
viru
matur
may
influenc
viru
adsorpt
penetr
transport
viral
glycoprotein
proteolyt
cleavag
precursor
protein
associ
spike
glycoprotein
antigen
semliki
forest
viru
sfv
togaviru
contain
nucleocapsid
protein
c
three
envelop
glycoprotein
el
previous
observ
viru
matur
could
inhibit
impair
glycosyl
eg
treatment
infect
cell
tunicamycin
use
polyclon
antisera
shown
addit
antigen
glycoprotein
carbohydr
side
chain
treatment
tunicamycin
truncat
chain
treatment
differ
viru
particl
use
six
monoclon
antibodi
mab
specif
six
epitop
af
virion
recent
found
chang
antigen
virion
sfv
propag
cell
presenc
nmethylldeoxynojirimycin
mdn
releas
infecti
viru
particl
contain
mannoserich
carbohydr
side
chain
composit
gi
glcnac
epitop
react
well
epitop
c
e
react
less
epitop
b
f
slightli
addit
sampl
respect
lysat
treat
rabbit
antiserum
k
precipit
structur
compon
virion
immunocomplex
remov
protein
acontain
staphylococcu
aureu
cell
wall
sdspage
nonreduc
condit
radioact
detect
fluorographi
note
addit
precipit
band
c
e
band
respect
due
differ
number
attach
carbohydr
side
chain
respect
report
result
obtain
reaction
viral
glycoprotein
mab
infect
cell
briefli
chicken
embryo
cell
cec
infect
sfv
moi
cultur
medium
mem
glucos
contain
either
mdn
addit
h
pi
viral
protein
label
amersham
buchler
mlplastic
petri
dish
lysat
prepar
radioimmunoprecipit
rip
describ
previous
analyz
mab
polyclon
rabbit
antiserum
k
precipit
structur
sfv
protein
immunecomplex
subject
sdspage
accord
nonreduc
condit
separ
protein
detect
fluorographi
describ
previous
treatment
sfvinfect
cell
epitop
c
e
access
intracellular
precursor
fig
result
obtain
treatment
tunicamycin
shown
result
indic
structur
intracellular
respect
differ
correct
glycosyl
protein
observ
agreement
result
obtain
previous
sugarfre
apoform
expos
antigen
site
absent
virion
first
step
oligosaccharid
process
block
mdn
epitop
except
f
access
fig
control
infect
cell
epitop
access
shown
epitop
f
recogn
complex
carbohydr
side
chain
postul
previous
interest
observ
pattern
access
epitop
treatment
mdn
ident
intracellular
viral
glycoprotein
virion
result
explain
structur
antigen
chang
occur
viru
bud
process
indic
composit
attach
carbohydr
side
chain
influenc
viru
antigen
import
antibodi
reactiv
author
also
report
hivinfect
cell
treat
mdn
access
virion
protein
mab
alter
well
bioactiv
conform
